MAS | Jotup

GLMX Continues Global Expansion with Regulatory Approval from Monetary Authority of Singapore

Retrieved on:

понедельник, июня 3, 2024

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- GLMX Technologies LLC (GLMX), a leading technology provider for global money market trading, including repurchase agreements, securities lending and time deposits, has been designated by the Monetary Authority of Singapore (MAS) as a Recognized Market Operator (RMO) effective May 28, 2024.

Key Points:

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- GLMX Technologies LLC (GLMX), a leading technology provider for global money market trading, including repurchase agreements, securities lending and time deposits, has been designated by the Monetary Authority of Singapore (MAS) as a Recognized Market Operator (RMO) effective May 28, 2024.
This recognition from the MAS allows GLMX to provide its award-winning platform to financial institutions based in Singapore, an important global trading hub.
The approval also enables GLMX to expand its global footprint while demonstrating its commitment to regulatory compliance.
“Becoming an RMO in Singapore is a significant step for GLMX as this reinforces the Firm's commitment to markets throughout Asia,” said GLMX CEO and co-founder Glenn Havlicek.

Singapore Embedded Finance Business Report 2024-2029: Supportive Regulatory Landscape, Demand for Seamless Financial Experiences, Rise of E-commerce and Platform-based Businesses - ResearchAndMarkets.com

Retrieved on:

четверг, мая 30, 2024

With over 75+ KPIs at the country level, this report provides a comprehensive understanding of embedded finance market dynamics, market size and forecast.

Key Points:

With over 75+ KPIs at the country level, this report provides a comprehensive understanding of embedded finance market dynamics, market size and forecast.
Singapore, with its strong financial infrastructure and focus on innovation, is poised to become a regional leader in embedded finance.
Major Innovation and Deals of Singapore Embedded Finance Market:
Singapore as the Embedded Finance Hub: KPMG to launch Singapore's first Embedded Finance Hub.
Embedded Finance Startups in Singapore: There are 66 Embedded Finance startups in Singapore which include Bolttech, Atome, Decentro, Crayon Data, and MatchMove.

AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress

Retrieved on:

четверг, мая 30, 2024

The findings highlight innovative approaches, including AI integration, and the real-world clinical utility of CareDx’s solutions, emphasizing their significant impact on patient care and outcomes in kidney, heart, and lung transplantation.

Key Points:

The findings highlight innovative approaches, including AI integration, and the real-world clinical utility of CareDx’s solutions, emphasizing their significant impact on patient care and outcomes in kidney, heart, and lung transplantation.
“The additive value of artificial intelligence to our transplant solutions holds significant promise,” said John W. Hanna, CareDx President and CEO.
Characterization of GEP and dd-cfDNA Profile with Long-Term Malignancy Risk Post-Cardiac Transplant, L. Chen, D. H. Lee, E. Czinn, et al.
The integration of AI in predicting rejection risk marks a significant leap forward in patient care," said Kiran Khush, MD, MAS, Cardiologist, Professor of Cardiovascular Medicine, Stanford Medicine.

MultiBank Group Receives “Best Global Forex Broker” Award at Forex Traders Summit Dubai 2024

Retrieved on:

вторник, мая 28, 2024

MultiBank Group, a leading forex broker, has achieved a significant milestone by clinching the prestigious “Best Global Forex Broker” award at the highly acclaimed Forex Traders Summit Dubai 2024.

Key Points:

MultiBank Group, a leading forex broker, has achieved a significant milestone by clinching the prestigious “Best Global Forex Broker” award at the highly acclaimed Forex Traders Summit Dubai 2024.
View the full release here: https://www.businesswire.com/news/home/20240528666363/en/
MultiBank Group Receives “Best Global Forex Broker” Award at Forex Traders Summit Dubai 2024 (Graphic: Business Wire)
MultiBank Group’s impressive track record includes over 65 prestigious awards.
The recent accolade as the “Best Global Forex Broker” at the Forex Traders Summit Dubai 2024 underscores the Group’s unwavering commitment to delivering exceptional service, cutting-edge technology, and unparalleled trading conditions.
Since its establishment in 2005, MultiBank Group has garnered a dedicated following, exceeding one million traders across 90+ countries.

Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome

Retrieved on:

пятница, мая 24, 2024

WALTHAM, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi®), today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation to emapalumab-lzsg being investigated as a potential therapeutic option in patients with Macrophage Activation Syndrome (MAS).

Key Points:

WALTHAM, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi®), today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation to emapalumab-lzsg being investigated as a potential therapeutic option in patients with Macrophage Activation Syndrome (MAS).
Emapalumab is a fully human, anti-IFNγ monoclonal antibody that binds free and receptor-bound IFNγ, neutralizing its biological activity.
Fast track designation is designed to facilitate the development and expedite the review of medicines to treat serious conditions that may fill an unmet medical need.
MAS is a severe complication of rheumatic diseases, most frequently in Still’s disease including systemic juvenile idiopathic arthritis (sJIA).

MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa

Retrieved on:

четверг, мая 16, 2024

Sonelokimab is designed to directly target sites of inflammation by inhibiting the IL-17A/A, IL-17A/F, and IL-17F/F dimers and to penetrate difficult-to-reach inflamed tissues.

Key Points:

Sonelokimab is designed to directly target sites of inflammation by inhibiting the IL-17A/A, IL-17A/F, and IL-17F/F dimers and to penetrate difficult-to-reach inflamed tissues.
Following the positive results from the landmark Phase 2 MIRA trial, the Phase 3 VELA program is expected to enroll 800 patients across VELA-1 and VELA-2.
The Phase 3 program will use a protocol design consistent with the Phase 2 MIRA trial, which identified the optimal dose of sonelokimab for HS.
The topline primary endpoint readout (week 16) from the VELA program is expected as of mid-2025.

Landmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies

Retrieved on:

четверг, мая 16, 2024

Follow-up endomyocardial biopsies (EMB) are performed at the lowest rate (8.8%) following a dual-negative HeartCare result, and at the highest rate (35.4%) following a dual positive HeartCare result.

Key Points:

Follow-up endomyocardial biopsies (EMB) are performed at the lowest rate (8.8%) following a dual-negative HeartCare result, and at the highest rate (35.4%) following a dual positive HeartCare result.
The rate of biopsies performed in response to a single positive result is 56% lower than dual-positive HeartCare results.
Excellent clinical outcomes were observed in patients managed with HeartCare including fewer follow-up endomyocardial biopsies, 95% survival and 97% with normal allograft function at two years post-transplantation.
The published study was designed to evaluate the utility of combined molecular testing using HeartCare for acute cellular rejection (ACR) surveillance.

Masco Corporation Declares Quarterly Dividend

Retrieved on:

пятница, мая 10, 2024

Home Goods, Construction & Property, Other Manufacturing, Building Systems, Chemicals, Plastics, Other Construction & Property, Manufacturing, Retail, Corporation, Masco, MAS

Masco Corporation (NYSE: MAS) announced that its Board of Directors declared a quarterly dividend of $0.29 per common share, payable on June 10, 2024, to shareholders of record on May 24, 2024.

Key Points:

Masco Corporation (NYSE: MAS) announced that its Board of Directors declared a quarterly dividend of $0.29 per common share, payable on June 10, 2024, to shareholders of record on May 24, 2024.
Headquartered in Livonia, Michigan, Masco Corporation is a global leader in the design, manufacture and distribution of branded home improvement and building products.
We leverage our powerful brands across product categories, sales channels and geographies to create value for our customers and shareholders.
For more information about Masco Corporation, visit www.masco.com .

XREX Singapore Receives MAS Major Payment Institution Licence

Retrieved on:

понедельник, мая 13, 2024

Partnership, Money, Financial Action Task Force, USD, Luigi, USDC, Digital, MPI, USDT, SGD, Singapore dollar, Hand, FATF, MAS, Cryptocurrency

SINGAPORE, May 12, 2024 /PRNewswire/ -- XREX Singapore , a blockchain-enabled financial institution specialising in cross-border payments in emerging markets, announced today that it has obtained the Major Payment Institution (MPI) Licence from the Monetary Authority of Singapore (MAS), the nation's central bank and financial regulator.

Key Points:

SINGAPORE, May 12, 2024 /PRNewswire/ -- XREX Singapore , a blockchain-enabled financial institution specialising in cross-border payments in emerging markets, announced today that it has obtained the Major Payment Institution (MPI) Licence from the Monetary Authority of Singapore (MAS), the nation's central bank and financial regulator.
With this licence in hand, XREX Singapore will endeavour to bring blockchain-enabled digital payment currencies to ubiquity."
XREX Singapore's licence encompasses a total of six payment services, namely:
ii) Domestic money transfer service;
iii) Cross-border money transfer service;
vi) Digital payment token service.
With XREX Singapore as the group's Asia Pacific headquarters, XREX looks forward to expanding its partnership with major banks, credit card institutions, and payment institutions to build next-generation financial systems that integrate traditional and blockchain finance," said XREX Co-founder and Group Chief Revenue Officer Winston Hsiao.

XREX Singapore Receives MAS Major Payment Institution Licence

Retrieved on:

понедельник, мая 13, 2024

Partnership, Money, Financial Action Task Force, USD, Luigi, USDC, Digital, MPI, USDT, SGD, Singapore dollar, Hand, FATF, MAS, Cryptocurrency

SINGAPORE, May 13, 2024 /PRNewswire/ -- XREX Singapore , a blockchain-enabled financial institution specialising in cross-border payments in emerging markets, announced today that it has obtained the Major Payment Institution (MPI) Licence from the Monetary Authority of Singapore (MAS), the nation's central bank and financial regulator.

Key Points:

SINGAPORE, May 13, 2024 /PRNewswire/ -- XREX Singapore , a blockchain-enabled financial institution specialising in cross-border payments in emerging markets, announced today that it has obtained the Major Payment Institution (MPI) Licence from the Monetary Authority of Singapore (MAS), the nation's central bank and financial regulator.
With this licence in hand, XREX Singapore will endeavour to bring blockchain-enabled digital payment currencies to ubiquity."
XREX Singapore's licence encompasses a total of six payment services, namely:
ii) Domestic money transfer service;
iii) Cross-border money transfer service;
vi) Digital payment token service.
With XREX Singapore as the group's Asia Pacific headquarters, XREX looks forward to expanding its partnership with major banks, credit card institutions, and payment institutions to build next-generation financial systems that integrate traditional and blockchain finance," said XREX Co-founder and Group Chief Revenue Officer Winston Hsiao.